Inhalers and nebulizers are necessary when managing chronic obstructive pulmonary disease (COPD). Both are designed to deliver medication directly to the lungs, which helps in reducing symptoms, ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...

The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...

(StatePoint) If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you receive can impact your health outcomes and quality of life. That ...

BURLINGAME, Calif., Jan. 16, 2024 /PRNewswire/ -- CoherentMI published a report, titled, Global Ultrasonic Nebulizer Market Size is estimated to grow from US$ 218.3 Million in 2023 and is forecast to ...

“Chronic Obstructive Pulmonary Disease, also known as COPD, is a group of diseases that block airflow into the lungs making it difficult for a person to breathe. Emphysema and Chronic Bronchitis are ...

Medicare classifies nebulizers as durable medical equipment (DME), which is covered under Part B. Part A may cover costs if needed during inpatient care in a clinic, hospital, or nursing facility.